CalciMedica Valuation Multiples

CalciMedica Overview

About CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Founded

2011

HQ

Employees

14

Website

calcimedica.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($24M)

EV

$7M

Valuation Multiples

Multiples.vc

Start free trial

CalciMedica Financials

CalciMedica reported last 12-month revenue of — and negative EBITDA of ($24M).

In the same LTM period, CalciMedica generated — in gross profit, ($24M) in EBITDA losses, and had net loss of ($28M).

CalciMedica P&L

In the most recent fiscal year, CalciMedica reported revenue of — and EBITDA of ($23M).

CalciMedica expects next 12-month revenue of XXX and NTM EBITDA of XXX

CalciMedica Stock Performance

CalciMedica has current market cap of $10M, and enterprise value of $7M.

CalciMedica's stock price is $0.63.

CalciMedica Valuation Multiples

CalciMedica trades at (0.3x) EV/EBITDA.

CalciMedica Financial Valuation Multiples

As of April 14, 2026, CalciMedica has market cap of $10M and EV of $7M.

Equity research analysts estimate CalciMedica's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

CalciMedica has a P/E ratio of (0.4x).

CalciMedica Margins & Growth Rates

CalciMedica's revenue in the last fiscal year grew by —.

CalciMedica's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.7M for the same period.

CalciMedica Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

CalciMedica M&A Activity

CalciMedica acquired XXX companies to date.

Last acquisition by CalciMedica was on XXXXXXXX, XXXXX. CalciMedica acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

CalciMedica Investment Activity

CalciMedica invested in XXX companies to date.

CalciMedica made its latest investment on XXXXXXXX, XXXXX. CalciMedica invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).